Matthew Foehr Bought 4.1 percent More Shares In OmniAb

OABI Stock  USD 3.52  0.07  1.95%   
Under 61% of OmniAb's investor base is looking to short. The analysis of the overall investor sentiment regarding OmniAb Inc suggests that many traders are alarmed. OmniAb's investing sentiment shows overall attitude of investors towards OmniAb Inc.
  
Potential OmniAb, Inc. shareholders may wish to note that the President, Matthew Foehr, recently bought...

Read at finance.yahoo.com
Yahoo News
  

OmniAb Fundamental Analysis

We analyze OmniAb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OmniAb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OmniAb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

OmniAb is currently under evaluation in target price category among its peers.

OmniAb Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OmniAb stock to make a market-neutral strategy. Peer analysis of OmniAb could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics with similar companies.

Peers

OmniAb Related Equities

PASGPassage Bio   1.92   
0%
18.0%
VRNAVerona Pharma   1.81   
0%
17.0%
PMVPPmv Pharmaceuticals   1.42   
0%
13.0%
ITOSIteos Therapeutics   1.29   
0%
12.0%
ACETAdicet Bio   1.12   
0%
10.0%
EWTXEdgewise Therapeutics   0.28   
0%
2.0%
KROSKeros Therapeutics   0.27   
0%
2.0%
IDYAIdeaya Biosciences   0.48   
4.0%
0%
ERASErasca   0.71   
6.0%
0%
GLUEMonte Rosa   1.03   
9.0%
0%
OLMAOlema Pharmaceuticals   1.29   
12.0%
0%
CGEMCullinan Oncology   1.29   
12.0%
0%
LEGNLegend Biotech   1.30   
12.0%
0%
IPSCCentury Therapeutics   1.43   
13.0%
0%
IKNAIkena Oncology   2.14   
20.0%
0%
VORVor Biopharma   4.55   
43.0%
0%
BCABBioatla   10.53   
100.0%
0%

Complementary Tools for OmniAb Stock analysis

When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account